Cited by 3,125Heart Failure Treatment and ManagementElectrolyte and hormonal disordersCardiac Fibrosis and Remodeling

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure

Cohn, Jay N., Levine, T. Barry, Olivari, Maria Teresa, Garberg, Victoria, Lura, Dennis, Francis, Gary S., Simon, Ada B., Rector, Thomas·1984·New England Journal of Medicine

DOI 10.1056/nejm198409273111303

Open this paper in CoChat — free account

Abstract

Hemodynamics, plasma norepinephrine, and plasma renin activity were measured at supine rest in 106 patients (83 men and 23 women) with moderate to severe congestive heart failure. During follow-up lasting 1 to 62 months, 60 patients died (57 per cent); 47 per cent of the deaths were sudden, and 45 per cent were related to progressive heart failure. Statistically unrelated to the risk of mortality were cause of disease (60 patients had coronary disease, and 46 had cardiomyopathy), age (mean, 54.8 years), cardiac index (mean, 2.11 liters per minute per square meter of body-surface area), pulmonary wedge pressure (mean, 24.5 mm Hg), and mean arterial pressure (mean, 83.2 mm Hg). A multivariate analysis of the five significant univariate prognosticators--heart rate (mean, 84.4 beats per minute), plasma renin activity (mean, 15.4 ng per milliliter per hour), plasma norepinephrine (mean, 700 pg per milliliter), serum sodium (mean, 135.7 mmol per liter), and stroke-work index (mean, 21.0 g-meters per square meter)--found only plasma norepinephrine to be independently (P = 0.002) related to the subsequent risk of mortality. Norepinephrine was also higher in patients who died from progressive heart failure than in those who died suddenly. These data suggest that a single resting venous blood sample showing the plasma norepinephrine concentration provides a better guide to prognosis than other commonly measured indexes of cardiac performance.

Integrity signals

Registry

Crossref · 10.1056/nejm198409273111303

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Fundamentals of Biostatistics.
(1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-4-873 · Cited by 4,573
A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,407
Plasma norepinephrine in congestive heart failure
Thomas, J. A., & Marks, B. H. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90162-5 · Cited by 925
A simplified radiometric assay for plasma norepinephrine and epinephrine
Passon, P. G., & Peuler, J. D. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90517-4 · Cited by 637
Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure
Levine, T. B., Francis, G. S., Goldsmith, S. R., Simon, A. B., & Cohn, J. N. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90243-0 · Cited by 614
Self-citation
Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man
Lake, C., Ziegler, M. G., & Kopin, I. J. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90210-1 · Cited by 548
Determinants of Survival in Patients with Ventricular Tachyarrhythmias
Swerdlow, C. D., Winkle, R. A., & Mason, J. W. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306163082402 · Cited by 508
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.
Robertson, D., Johnson, G., Robertson, R. M., Nies, A. S., Shand, D. G., & Oates, J. A. (1979) · Circulation · doi:10.1161/01.cir.59.4.637 · Cited by 467
Augmentation of the Plasma Nor-Epinephrine Response to Exercise in Patients with Congestive Heart Failure
Chidsey, C. A., Harrison, D. C., & D, E. B. M. (1962) · New England Journal of Medicine · doi:10.1056/nejm196209272671305 · Cited by 439

Show all 23 references

Research works printed but not linked: 2

Hopkins A. Survival analysis with covariates — Cox models. In: BMDP statistical software. Berkeley, Calif.: University of California Press, 1983: 576–94.
10.2307/2281868 · DOI · Paper page

Sorted by citations

Items 801–900 of 1,002

Cardiovascular gene therapy for myocardial infarction
Scimia, M. C., Gumpert, A. M., & Koch, W. J. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.866085 · Cited by 56
Downregulated Kv4.3 expression in the RVLM as a potential mechanism for sympathoexcitation in rats with chronic heart failure
Gao, L., Li, Y., Schultz, H. D., Wang, W., Wang, W. T., Finch, M., Smith, L. M., & Zucker, I. H. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00145.2009 · Cited by 56
Nutritional abnormalities contributing to cachexia in chronic illness
Witte, K. K., & Clark, A. L. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00231-0 · Cited by 56
Effects of Chronic Calcium Channel Blockade on Sympathetic Nerve Activity in Hypertension
Binggeli, C., Corti, R., Sudano, I., Lüscher, T. F., & Noll, G. (2002) · Hypertension · doi:10.1161/01.hyp.0000013264.41234.24 · Cited by 56
Beta-adrenergic receptor– G protein–adenylyl cyclase signal transduction in the failing heart
Vatner, D. E., Asai, K., Iwase, M., Ishikawa, Y., Shannon, R. P., Homcy, C. J., & Vatner, S. F. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00266-0 · Cited by 56
Molecular aspects of adrenergic signal transduction in cardiac failure
Hajjar, R. J., Müller, F. U., Schmitz, W. L., Schnabel, P., & Böhm, M. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050276 · Cited by 55
Transvenous Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea: Five-Year Safety and Efficacy Outcomes
Costanzo, M. R., Javaheri, S., Ponikowski, P. P., Oldenburg, O., Augostini, R. S., Goldberg, L. R., Stellbrink, C., Fox, H., Schwartz, A. R., Gupta, S. K., et al. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s300713 · Cited by 57
Effects of Cardiac Dysfunction on Non-Hypercapnic Central Sleep Apnea
Solin, P., Roebuck, T., Swieca, J., Walters, E. H., & Naughton, M. T. (1998) · CHEST Journal · doi:10.1378/chest.113.1.104 · Cited by 55
Sympathetic Nervous System Moves Toward Center Stage in Cardiovascular Medicine
Esler, M. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02439 · Cited by 55
Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system?
Siddiqi, L., Joles, J. A., Grassi, G. M., & Blankestijn, P. J. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832b521b · Cited by 55
Stroke Incidence and Impact of Continuous-Flow Left Ventricular Assist Devices on Cerebrovascular Physiology
Cornwell, W., Ambardekar, A., Tran, T., Pal, J., Cava, L. F., Lawley, J., Tarumi, T., Cornwell, C., & Aaronson, K. (2019) · Stroke · doi:10.1161/strokeaha.118.022967 · Cited by 51
Recovery of the cardiac adrenergic nervous system after long-term beta-blocker therapy in idiopathic dilated cardiomyopathy: assessment by increase in myocardial 123I-metaiodobenzylguanidine uptake.
Lotze, U., Kaepplinger, S., Kober, A., Richartz, B. M., Gottschild, D., & Figulla, H. R. (2001) · PubMed · Cited by 55
Spontaneous Activation of β2- but Not β1-Adrenoceptors Expressed in Cardiac Myocytes from β1β2Double Knockout Mice
Zhou, Y.-Y., Yang, D., Zhu, W., Zhang, S.-J., Wang, D.-J., Rohrer, D. K., Devic, E., Kobilka, B. K., Lakatta, E. G., Cheng, H., et al. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.5.887 · Cited by 55
The molecular and cellular pathophysiology of heart failure
Piano, M. R., Bondmass, M. D., & Schwertz, D. W. (1998) · Heart & Lung · doi:10.1016/s0147-9563(98)90063-2 · Cited by 54
Atrial overdrive pacing compared to CPAP in patients with obstructive sleep apnoea syndrome
Unterberg‐Buchwald, C., Lüthje, L., Szych, J., Vollmann, D., Hasenfuss, G. P., & Andreas, S. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi448 · Cited by 55
Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure
Tsutamoto, T., Wada, A., Macda, K., 久永, 智., 深井, 大., Maeda, Y., Ohnishi, M., Mabuchi, N., & Kinoshita, M. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)80014-2 · Cited by 55
Association of Short-term Heart Rate Variability and Sudden Unexpected Death in Epilepsy
Sivathamboo, S., Friedman, D. J., Laze, J., Nightscales, R., Chen, Z. Z., Kuhlmann, L., Devore, S., Macefield, V. G., Kwan, P., D'Souza, W. J., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000012946 · Cited by 52
Alterations in Adrenergic Receptor Signaling in Heart Failure
Lamba, S., & Abraham, W. T. (2000) · Heart Failure Reviews · doi:10.1023/a:1009885822076 · Cited by 54
Effects of carvedilol on myocardial sympathetic innervation in patients with chronic heart failure.
Solal, A. C., Rouzet, F., Berdeaux, A., Guludec, D. L., Abergel, É., Syrota, A., & Merlet, P. (2005) · PubMed · Cited by 54
Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat
Chung, E. S., Perlini, S., Aurigemma, G. P., Fenton, R. A., Dobson, J. G., & Meyer, T. E. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816120-00015 · Cited by 54
Consequences of the Increased Autonomic Nervous Drive in Hypertension, Heart Failure and Diabetes
Julius, M. (1998) · Blood Pressure · doi:10.1080/080370598438410-1 · Cited by 55
Post-Exercise Heart Rate Recovery Independently Predicts Mortality Risk in Patients With Chronic Heart Failure
Tang, Y.-D., Dewland, T. A., Wencker, D., & Katz, S. D. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.06.437 · Cited by 53
Targeting Myocardial β-Adrenergic Receptor Signaling and Calcium Cycling for Heart Failure Gene Therapy
Pleger, S. T., Boucher, M., Most, P., & Koch, W. J. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.01.003 · Cited by 54
Norepinephrine Turnover Is Increased in Suprabulbar Subcortical Brain Regions and Is Related to Whole-Body Sympathetic Activity in Human Heart Failure
Aggarwal, A., Esler, M., Lambert, G. W., Hastings, J. A., Johnston, L., & Kaye, D. M. (2002) · Circulation · doi:10.1161/hc0902.105724 · Cited by 54
ß-Blocker Timolol Prevents Arrhythmogenic Ca2+ Release and Normalizes Ca2+ and Zn2+ Dyshomeostasis in Hyperglycemic Rat Heart
Tuncay, E., Okatan, E. N., Vassort, G., & Turan, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071014 · Cited by 54
Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure
Aaser, E., Gullestad, L. L., Tølløfsrud, S., Lundberg, J. O., Hall, C., Djøseland, O., KJEKSHUS, J. K., & Forfang, K. (1997) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519709099409 · Cited by 54
Effects of posture on cardiac autonomic nervous activity in patients with congestive heart failure
Miyamoto, S., Fujita, M., Sekiguchi, H., Okano, Y., Nagaya, N., Ueda, K., Tamaki, S., Nohara, R., Eiho, S., & Sasayama, S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01249-9 · Cited by 54
Rapid Resting Heart Rate: A Simple and Powerful Predictor of Osteoporotic Fractures and Mortality in Older Women
Kado, D. M., Lui, L., & Cummings, S. R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50110.x · Cited by 54
Sympathetic Nervous System Activity and Ventricular Tachyarrhythmias: Recent Advances
Anderson, K. P. (2003) · Annals of Noninvasive Electrocardiology · doi:10.1046/j.1542-474x.2003.08112.x · Cited by 55
A TRIAL OF THE BETA-BLOCKER BUCINDOLOL IN PATIENTS WITH ADVANCED CHRONIC HEART FAILURE
Nvestigators, T. R. I. (2001) · Cited by 54
Effect of Age on Autonomic and Cardiac Responses in a Rat Stroke Model
Hachinski, V., Wilson, J. X., Smith, K. E., & Cechetto, D. F. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530310032009 · Cited by 54
Cardiac adenylyl cyclase, beta-adrenergic receptors, and G proteins in salt-sensitive hypertension.
Böhm, M., Gierschik, P., Knorr, A., Schmidt, U. H., Weismann, K., & Erdmann, E. (1993) · Hypertension · doi:10.1161/01.hyp.22.5.715 · Cited by 52
OXIDATIVE STRESS AND THE PATHOGENESIS OF HEART FAILURE
Ball, A. M. M., & Sole, M. J. (1998) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70043-6 · Cited by 53
The pathophysiology of advanced heart failure
Baig, M. K., Mahon, N., McKenna, W. J., Caforio, A. L. P., Bonow, R. O., Francis, G. S., & Gheorghiade, M. (1999) · Heart & Lung · doi:10.1053/hl.1999.v28.a97762 · Cited by 63
Self-citation
Role of the Sympathetic Nervous System in Hypertension and Hypertension-Related Cardiovascular Disease
Seravalle, G., Mancia, G., & Grassi, G. M. (2014) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-014-0056-1 · Cited by 53
Determinants of prognosis in nonischemic dilated cardiomyopathy
Grzybowski, J., Bilińska, Z. T., Rużyłło, W., Kupść, W., Michalak, E., Szcześniewska, D., Popławska, W., & Rydlewska-Sadowska, W. (1996) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(96)80026-1 · Cited by 53
nNOS gene transfer to RVLM improves baroreflex function in rats with chronic heart failure
Wang, Y., Patel, K. P., Cornish, K. G., Channon, K. M., & Zucker, I. H. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00239.2003 · Cited by 53
Exchange Protein Directly Activated by cAMP Mediates Slow Delayed-Rectifier Current Remodeling by Sustained β-Adrenergic Activation in Guinea Pig Hearts
Aflaki, M., Qi, X., Xiao, L., Ördög, B., Tadevosyan, A., Luo, X., Maguy, A., Shi, Y., Tardif, J., & Nattel, S. (2014) · Circulation Research · doi:10.1161/circresaha.113.302982 · Cited by 57
Integration of renal sensory afferents at the level of the paraventricular nucleus dictating sympathetic outflow
Zheng, H., & Patel, K. P. (2016) · Autonomic Neuroscience · doi:10.1016/j.autneu.2016.08.008 · Cited by 53
Cardiac autonomic innervation
Jamali, H. K., Waqar, F., & Gerson, M. C. (2016) · Journal of Nuclear Cardiology · doi:10.1007/s12350-016-0725-7 · Cited by 53
Neurohormonal Blockade in Heart Failure
von Lueder, T. G., Kotecha, D., Atar, D., & Hopper, I. (2017) · Cardiac failure review · doi:10.15420/cfr.2016:22:2 · Cited by 53
Quantification of sympathetic hyperinnervation and denervation after myocardial infarction by three-dimensional assessment of the cardiac sympathetic network in cleared transparent murine hearts
Yokoyama, T., Lee, J.-K., Miwa, K., Opthof, T., Tomoyama, S., Nakanishi, H., Yoshida, A., Yasui, H., Iida, T., Miyagawa, S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182072 · Cited by 57
Cardiovascular Reactivity to Mental Stress and Mortality in Patients With Heart Failure
Kupper, N. H. M., Denollet, J., Widdershoven, J. W. M. G., & Kop, W. J. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2014.12.016 · Cited by 53
Modulation of peripheral sympathetic nerve transmission
Francis, G. S. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90382-8 · Cited by 53
Self-citation
Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure
Isnard, R., Pousset, F., Trochu, J., Chafirovskaı̈a, O., Carayon, A., Golmard, J., Lechat, P. P., Thomas, D., Bouhour, J.-B., & Michel Komajda, N. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00957-7 · Cited by 53
Relevance of Na+–Ca2+ exchange in heart failure
Schillinger, W. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00826-x · Cited by 53
Isolation and Characterization of the Murine Cardiotrophin-1 Gene: Expression and Norepinephrine-Induced Transcriptional Activation
Funamoto, M., Hishinuma, S., Fujio, Y., Matsuda, Y., Kunisada, K., Oh, H., Negoro, S., Tone, E., Kishimoto, T., & Yamauchi‐Takihara, K. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1161 · Cited by 53
Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension
Sakata, K., Shirotani, M., Yoshida, H., & Kurata, C. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00261-7 · Cited by 53
Transmural heterogeneity of norepinephrine uptake in failing human hearts
Beau, S. L., & Saffitz, J. E. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90739-0 · Cited by 53
Hyperglycaemia, Diabetes and Myocardial Infarction
Yudkin, J. S., & Oswald, G. A. (1987) · Diabetic Medicine · doi:10.1111/j.1464-5491.1987.tb00821.x · Cited by 53
Plasma Big Endothelin-1, Atrial Natriuretic Peptide, Aldosterone, and Norepinephrine Concentrations in Normal Doberman Pinschers and Doberman Pinschers with Dilated Cardiomyopathy
O’Sullivan, M. L., O’Grady, M. R., & Minors, S. L. (2007) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2007.tb02933.x · Cited by 52
Psychobiology of depression/distress in congestive heart failure
York, K. M., Hassan, M., & Sheps, D. S. (2008) · Heart Failure Reviews · doi:10.1007/s10741-008-9091-0 · Cited by 54
Sympathetic activation in congestive heart failure: an updated overview
Grassi, G. M., Quarti‐Trevano, F., & Esler, M. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09901-2 · Cited by 54
Impact of Aspirin on Takotsubo Syndrome: A Propensity Score-Based Analysis of the InterTAK Registry
D’Ascenzo, F., Gili, S., Bertaina, M., Iannaccone, M., Cammann, V. L., Vece, D. D., Kato, K., Saglietto, A., Szawan, K. A., Frangieh, A. H., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1698 · Cited by 53
Neuroendocrine changes in heart failure and their clinical relevance
Parmley, W. W. (1995) · Clinical Cardiology · doi:10.1002/clc.4960180804 · Cited by 50
The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure
Swedberg, K. B., Bergh, C., Dickstein, K., McNay, J. L., & Steinberg, M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00565-3 · Cited by 52
Effect of Atrial Natriuretic Peptide on Muscle Sympathetic Activity and Its Reflex Control in Human Heart Failure
Abramson, B. L., Ando, S., Notarius, C. F., Rongen, G. A. P. J. M., & Floras, J. S. (1999) · Circulation · doi:10.1161/01.cir.99.14.1810 · Cited by 52
Relation between severity of disease and impairment of heart rate variability parameters in patients with chronic congestive heart failure secondary to coronary artery disease
Szabó, B. M., van Veldhuisen, D. J., Brouwer, J., Haaksma, J., & Lie, K. I. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80204-5 · Cited by 51
Angiotensin-Converting Enzyme Inhibition and Radial Artery Compliance in Patients With Congestive Heart Failure
Giannattasio, C., Failla, M., Stella, M. L., Mangoni, A. A., Turrini, D., Carugo, S., Pozzi, M., Grassi, G. M., & Mancia, G. (1995) · Hypertension · doi:10.1161/01.hyp.26.3.491 · Cited by 52
Regulation of cardiac beta-adrenergic receptors by captopril. Implications for congestive heart failure.
Maisel, A. S., Phillips, C., Michel, M. C., Ziegler, M. G., & Carter, S. M. (1989) · Circulation · doi:10.1161/01.cir.80.3.669 · Cited by 52
Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy
Fujimura, M., Yasumura, Y., Ishida, Y., Nakatani, S., Komamura, K., Yamagishi, M., & Miyatake, K. (2000) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(00)80004-4 · Cited by 51
Pharmacodynamic Action and Pharmacokinetics of Moxonidine After Single Oral Administration in Hypertensive Patients
Kirch, W., Hutt, H., & Plänitz, V. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb01850.x · Cited by 52
Editorial
Ewy, G. A. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00596-8 · Cited by 52
Respiratory correlates of muscle sympathetic nerve activity in heart failure.
Naughton, M. T., Floras, J. S., Rahman, M. A., Jamal, M., & Bradley, T. D. (1998) · PubMed · Cited by 51
Iodine-123 mIBG Imaging for Predicting the Development of Atrial Fibrillation
Akutsu, Y., Kaneko, K., Kodama, Y., Li, H., Suyama, J., Shinozuka, A., Gokan, T., Hamazaki, Y., Tanno, K., & Kobayashi, Y. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.10.005 · Cited by 51
Effects of exercise training on neurovascular control and skeletal myopathy in systolic heart failure
Negrão, C. E., Middlekauff, H. R., Gomes-Santos, I. L., & Antunes‐Correa, L. M. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00830.2014 · Cited by 51
Applying heart failure guidelines to adult congenital heart disease patients
Shaddy, R. E., & Webb, G. D. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.2.165 · Cited by 51
Activation of Central Angiotensin Type 2 Receptors by Compound 21 Improves Arterial Baroreflex Sensitivity in Rats With Heart Failure
Gao, J., Zucker, I. H., & Gao, L. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu044 · Cited by 51
Beta Blocker dose and Markers of Sympathetic Activation in Heart Failure Patients: Interrelationships and Prognostic Significance
Solal, A. C., Jacobson, A. F., & Piña, I. L. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12153 · Cited by 51
Knockout of β 1 ‐ and β 2 ‐adrenoceptors attenuates pressure overload‐induced cardiac hypertrophy and fibrosis
Kiriazis, H., Wang, K. K., Xu, Q., Gao, X., Ming, Z., Su, Y. R., Moore, X., Lambert, G. W., Gibbs, M. E., Dart, A. M., et al. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707622 · Cited by 51
Cardiac Sympathetic Responses to Acute Vasodilation
Newton, G. E., & Parker, J. D. (1996) · Circulation · doi:10.1161/01.cir.94.12.3161 · Cited by 50
(-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through β2-adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling
Molenaar, P., Francis, S. M. S., Sarsero, D., Chen, L., Semmler, A., Carle, A. D., Yang, I. A., Bartel, S., Vetter, D., Beyerdörfer, I., et al. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0138-x · Cited by 51
Effects of amlodipine on exercise tolerance, quality of life, and left ventricular function in patients with heart failure from left ventricular systolic dysfunction
Udelson, J. E., DeAbate, C. A., Berk, M. R., Neuberg, G. W., Packer, M., Vijay, N. K., Gorwitt, J. K., Smith, W. B., Kukin, M. L., LeJemtel, T. H., et al. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90095-4 · Cited by 51
Self-citation
Baroreceptor dysfunction induced by nitric oxide synthase inhibition in humans
Spieker, L. E., Corti, R., Binggeli, C., Lüscher, T. F., & Noll, G. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00674-4 · Cited by 51
Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group.
Sigurðsson, A. F., Amtorp, O., GUNDERSEN, T., Nilsson, B., Remes, J., & Swedberg, K. B. (1994) · Heart · doi:10.1136/hrt.72.5.422 · Cited by 51
Mechanisms of Arrhythmias in Heart Failure
VERMEULEN, J. T. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00902.x · Cited by 50
Isoproterenol sensitivity of isolated cardiac myocytes from rats with monocrotaline-induced right-sided hypertrophy and heart failure
Vescovo, G. M., Jones, S., Harding, S. E., & Poole-Wilson, P. A. (1989) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(89)90803-1 · Cited by 51
A possible role of catecholamines in atherogenesis and subsequent complications of atherosclerosis
Bauch, H. ‐., Grünwald, J., Vischer, P., Gerlach, U., & Hauss, W. H. (1987) · Experimental Pathology · doi:10.1016/s0232-1513(87)80001-4 · Cited by 51
Enalapril Reduces QTc Dispersion in Mild Congestive Heart Failure Secondary to Coronary Artery Disease
Barr, C. S., Naas, A. A., Fenwick, M., & Struthers, A. D. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00756-4 · Cited by 49
Dilated cardiomyopathy and myocarditis: Natural history, etiology, clinical manifestations, and management
Kopecky, S. L., & Gersh, B. J. (1987) · Current Problems in Cardiology · doi:10.1016/0146-2806(87)90002-8 · Cited by 50
Myocardial beta adrenoceptor and voltage sensitive calcium channel changes in a canine model of chronic heart failure
Gengo, P. J. (1992) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(92)93100-x · Cited by 51
Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial infarction
Sweet, C. S., Ludden, C. T., Stabilito, I. I., Emmert, S. E., & Heyse, J. F. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90630-9 · Cited by 51
Evidence against spare or uncoupled β-adrenoceptors in the human heart
Schwinger, R. H. G., Böhm, M., & Erdmann, E. (1990) · American Heart Journal · doi:10.1016/s0002-8703(05)80329-1 · Cited by 51
Dobutamine Enhances Cardiodepressant Effects of Receptor-Mediated Coronary Endothelial Stimulation
Bartúnek, J., Shah, A. M., Vanderheyden, M., & Paulus, W. J. (1997) · Circulation · doi:10.1161/01.cir.95.1.90 · Cited by 51
Changes in Heart Rate Variability Are Correlated to Hemodynamic Improvement With Chronic CARVEDILOL Therapy in Heart Failure
Bullinga, J. R., Alharethi, R. A., Schram, M. S., Bristow, M. R., & Gilbert, E. M. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2005.06.435 · Cited by 50
Autonomic nervous system and cardiac neuro-signaling pathway modulation in cardiovascular disorders and Alzheimer’s disease
Elia, A., & Fossati, S. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1060666 · Cited by 55
Dobutamine Stress Testing as a Diagnostic Tool for Evaluation of Myocardial Contractile Reserve in Asymptomatic or Mildly Symptomatic Patients With Dilated Cardiomyopathy
Kobayashi, M., Izawa, H., Cheng, X. W., Asano, H., Hirashiki, A., Unno, K., Ohshima, S., Yamada, T., Murase, Y., Kato, T., et al. (2008) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.04.012 · Cited by 50
A systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure.
de Peuter, O. R., Lussana, F., Peters, R. J. G., Buller, H. R., & Kamphuisen, P. W. (2009) · PubMed · Cited by 50
Respiratory-related heart rate variability in progressive experimental heart failure
Motte, S., Mathieu, M., Brimioulle, S., Pensis, A., Ray, L., Ketelslegers, J.-M., Montano, N., Naeije, R., van de Borne, P., & Entee, K. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01129.2004 · Cited by 49
Leptin, sympathetic nervous system, and baroreflex function
Grassi, G. M. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0075-8 · Cited by 50
Congestive heart failure: a half century perspective
D, E. B. M. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2614 · Cited by 50
Cardiac Troponin T vs Other Biochemical Markers in Patients With Congestive Heart Failure
Nishio, Y., Sato, Y., Taniguchi, R., Shizuta, S., Doi, T., Morimoto, T., Kimura, T., & Kita, T. (2007) · Circulation Journal · doi:10.1253/circj.71.631 · Cited by 50
Narrative Review: Pharmacotherapy for Chronic Heart Failure: Evidence from Recent Clinical Trials
Yan, A. T.-K., Yan, R. T., & Liu, P. P. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-2-200501180-00013 · Cited by 50
Ephedra–Associated Cardiomyopathy
Naik, S., & Freudenberger, R. S. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d408 · Cited by 50
An alternative approach for exercise prescription and efficacy testing in patients with chronic heart failure
Meyer, T., Görge, G., Schwaab, B., Hildebrandt, K., Walldorf, J., Schäfer, C., Kindermann, I., Scharhag, J., & Kindermann, W. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.12.006 · Cited by 50
Role of spectral measures of heart rate variability as markers of disease progression in patients with chronic congestive heart failure not treated with angiotensin-converting enzyme inhibitors
Panina, G., Khot, U. N., Nunziata, E., Cody, R. J., & Binkley, P. F. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90064-2 · Cited by 50
Adrenal adrenoceptors in heart failure
de Lucia, C., Femminella, G. D., Gambino, G., Pagano, G., Allocca, E., eRengo, C., Silvestri, C., Leosco, D., Ferrara, N., & Rengo, G. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00246 · Cited by 49
Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity
Hašková, P., Kovařı́ková, P., Koubková, L., Jirkovská, A., Macková, E., & Šimůnek, T. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.004 · Cited by 49
Activation of protein kinase C alters the intracellular distribution and mobility of cardiac Na+channels
Hallaq, H., Wang, D. W., Kunic, J. D., George, A. L., Wells, K. S., & Murray, K. T. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00817.2010 · Cited by 49
Biomarkers and heart disease.
Rr, S., Liu, L., Liu, M., Cao, Y., Li, X., Liu, H., Wang, J., & Py, Z. (2014) · PubMed · Cited by 49

Authors: Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T.
Affiliations: University of Minnesota (US)
ORCID: Cohn, Jay N.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1984-09-27
Volume: 311
Issue: 13
Pages: 819-823
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm198409273111303
OpenAlex: W2338638760
Cited by: 3,125
References: 23
Citations by year: 2026: 22 · 2025: 30 · 2024: 22 · 2023: 44 · 2022: 50 · 2021: 49 · 2020: 54 · 2019: 58 · 2018: 42 · 2017: 57 · 2016: 75 · 2015: 73 · 2014: 101 · 2013: 87 · 2012: 88
FWCI: 34.36
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Keywords: plasma norepinephrine, congestive heart failure, prognosis, mortality risk, plasma renin activity, hemodynamics, sudden death, progressive heart failure, prognostic factors, heart rate, stroke work index, serum sodium
MeSH terms: Age Factors, Blood Pressure, Female, Follow-Up Studies, Heart Failure, Heart Rate, Hemodynamics, Humans, Male, Middle Aged, Norepinephrine, Prognosis, Pulmonary Wedge Pressure, Renin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks